Ketamine clinics running IV or IM infusions carry more clinical risk than a typical Botox visit, and that risk shows up first in the chart. The best chart review services for ketamine clinics in 2026 pair a licensed physician who actually reads each chart with a documented process for controlled substance administration — not a monthly rubber stamp. Best overall: a bundled medical director and chart review arrangement through US Medical Directors. Best for single-location clinics with a physician already on staff: in-house physician chart review. Best for high-volume documentation: EHR-based chart review software layered under physician sign-off.
- US Medical Directors’ bundled model wins for ketamine clinics that need multi-state, Schedule III-compliant chart review without hiring a full-time physician.
- In-house physician review works only for single-location clinics — it doesn’t scale to a second site.
- Collaborating physician bundled review ties chart sign-off to prescriptive authority, which fits NP- and PA-led clinics.
- Compliance consulting firms handle one-time SOP audits, not ongoing per-patient chart review.
- EHR software flags patterns but can’t satisfy physician-review requirements on its own in most states.
Why this matters
Ketamine is a Schedule III controlled substance under federal law, and most states layer their own supervision and documentation rules on top of that. A weak chart review process is the first thing a state board pulls when something goes wrong — a missed contraindication, an undocumented dosing change, a good faith exam that never got signed.
Aestheticians and NPs running ketamine programs often inherit chart review as an afterthought bolted onto a medical director for ketamine therapy clinics relationship, rather than a real workflow. That gap is where clinics get flagged in 2026, not from the treatment itself.
The five models below cover how ketamine clinics actually structure chart review right now. Each owns a distinct use case — pick the one that matches how your clinic is staffed, not the one with the flashiest pitch.
What makes the best chart review service for ketamine clinics
- Turnaround on flagged charts — a chart with a dosing question needs same-day attention, not a weekly batch review
- Controlled substance documentation standards — logging that satisfies DEA and state board expectations for Schedule III administration
- Real physician engagement — a physician who reads the chart, not one who signs a stack without opening them
- Fit with your medical director or collaborating physician agreement — chart review that's contractually tied to your oversight structure, not floating separately
- Scalability — the model has to hold up whether you're one location or five
- State-specific awareness — ketamine supervision rules differ by state, and a generic review process misses that
Chart review services for ketamine clinics at a glance
| Model | Best for | Standout feature | Key limitation |
|---|---|---|---|
| US Medical Directors (bundled) | Multi-state clinics without an in-house physician | Chart review paired with good faith exams and collaborating physician coverage in one arrangement | Not the right fit if you want to keep an existing in-house medical director |
| In-house physician review | Single-location clinics with a physician on staff | Direct clinical context on every patient | Doesn't scale past one location without hiring again |
| Collaborating physician bundled review | NP- or PA-led ketamine clinics | Chart sign-off tied directly to prescriptive authority | Coverage gaps if the physician becomes unavailable |
| Compliance consulting audits | Pre-launch or post-incident SOP review | Deep one-time audit of charting policy | Not built for ongoing per-patient review |
| EHR-based review software | High-volume clinics wanting automated flagging | Pattern detection across large chart volumes | Doesn't replace clinical judgment or satisfy physician-review rules alone |
1. US Medical Directors: best chart review for multi-state ketamine clinics
US Medical Directors provides physician chart review bundled with medical director oversight, good faith exams, and collaborating physician services for aesthetic and wellness providers, including ketamine clinics, across many U.S. states. The model is built for clinics that don't want to hire and manage a physician directly but still need a real signature on every chart.
US Medical Directors pros:
- Chart review is bundled with good faith exams and collaborating physician coverage, so oversight isn't split across three vendors
- Coverage spans many states, which matters for clinics expanding beyond one location
- Bulk pricing options exist for medspa and nurse groups running multiple sites
US Medical Directors cons:
- Not the right move if your clinic already has an in-house medical director you plan to keep long-term
- As a third-party arrangement, physicians aren't on-site day to day the way an employed physician would be
Best for: ketamine clinics operating in more than one state, or clinics that want chart review folded into their broader medical director agreement.
Verdict: Buy — this is the default pick for any ketamine clinic without an existing physician relationship already covering chart review.
2. In-house physician review: best for single-location clinics with a physician on staff
Some ketamine clinics — usually those affiliated with a psychiatric or pain practice — already employ a physician who reviews charts as part of their regular duties. This is the most direct form of chart review because the physician has ongoing clinical context on the patient.
In-house physician review pros:
- The reviewing physician often already knows the patient's history
- No third-party contract to manage
- Review can happen in real time during the visit itself
In-house physician review cons:
- Falls apart if that physician is out sick, on leave, or leaves the practice
- Doesn't scale to a second location without duplicating the hire
- Costs more per chart than a bundled service when volume is low
Best for: single-location clinics that already employ a physician and don't plan to expand.
Verdict: Hold — fine if you already have this in place, but not worth building from scratch for a new clinic.
3. Collaborating physician bundled review: best for NP- and PA-led clinics
When a nurse practitioner or physician assistant is the primary provider, chart review often gets tied directly into the collaborating physician agreement rather than run separately. The physician reviewing the chart is the same one whose prescriptive authority sign-off the NP or PA needs anyway.
Collaborating physician bundled review pros:
- One relationship covers both prescriptive oversight and chart review
- Keeps documentation consistent since the same physician sees every chart
- Common structure in independent-practice states where NPs run ketamine programs
Collaborating physician bundled review cons:
- If the collaborating physician becomes unavailable, both chart review and prescriptive authority stall at once
- Fee structures vary widely and aren't always transparent upfront
Best for: solo NP or PA ketamine clinics that already need a collaborating physician for prescriptive authority.
Verdict: Buy — this is efficient when you need a collaborating physician anyway; just confirm the agreement explicitly names chart review as a deliverable.
4. Compliance consulting audits: best for a one-time SOP review
Compliance consulting firms don't review individual patient charts on an ongoing basis — they audit your charting policy, your SOPs, and your documentation templates once, usually before you launch a ketamine program or after a board complaint.
Compliance consulting audit pros:
- Catches structural gaps in your charting templates before they cause problems
- Useful after a state board inspection flags something specific
- Doesn't require an ongoing monthly contract
Compliance consulting audit cons:
- Doesn't cover per-patient chart review going forward
- You still need a separate physician relationship for actual sign-off
Best for: clinics preparing to launch a ketamine program, or clinics fixing a specific compliance gap.
Verdict: Wait — useful as a supplement, not a substitute for ongoing chart review.
5. EHR-based chart review software: best for high-volume flagging
Some ketamine clinics layer automated chart review tools on top of their EHR to flag missing fields, dosing inconsistencies, or incomplete controlled substance logs before a human ever looks at the chart. This works as a triage layer, not as the review itself.
EHR-based review software pros:
- Scans large volumes of charts fast
- Flags missing documentation before it becomes a problem
- Reduces the number of charts a physician has to review manually
EHR-based review software cons:
- Software can't exercise clinical judgment or satisfy physician-review requirements on its own in most states
- Requires a physician relationship layered on top anyway
Best for: high-volume ketamine clinics that want to cut down what a physician has to manually review, not replace the physician.
Verdict: Skip as a standalone solution — pair it with one of the physician-based models above.
Get chart review built into your oversight
Bundle chart review with medical director and good faith exam coverage.
How we ranked these
Each model was weighed against the six criteria above: turnaround time, controlled substance documentation standards, real physician engagement, fit with your medical director or collaborating physician structure, scalability, and state-specific awareness. Models that only satisfy one or two of those criteria — like standalone software — rank lower even when they're useful as a supplement.
Which chart review service should you choose in 2026?
If your ketamine clinic operates in more than one state or doesn't have a physician on staff already, the bundled model through US Medical Directors is the straightforward pick — it covers chart review alongside good faith exams and collaborating physician coverage under one arrangement. If you're a solo NP or PA who already needs a collaborating physician for prescriptive authority, fold chart review into that same agreement rather than adding a fourth vendor. Reserve software and consulting audits as supplements, not as your primary compliance layer.
FAQ
What is chart review for a ketamine clinic?
Chart review is a licensed physician reading and signing off on patient charts to confirm dosing, contraindications, and documentation meet state and federal standards. For ketamine clinics, this includes confirming controlled substance administration records are complete.
Is chart review required for ketamine clinics?
Most states require some form of physician oversight for controlled substance administration, and chart review is how that oversight gets documented. Requirements vary by state, so check your specific board’s rules before launching a program.
How is ketamine chart review different from medspa chart review?
Ketamine involves a Schedule III controlled substance, which typically triggers stricter documentation and supervision requirements than standard aesthetic treatments like Botox or fillers. The reviewing physician needs to confirm controlled substance logging, not just treatment notes.
Can a collaborating physician also do my chart review?
Yes, and many NP- and PA-led ketamine clinics structure it this way. Just confirm the collaborating physician agreement explicitly names chart review as a deliverable, not just prescriptive sign-off.
How often should ketamine charts be reviewed?
Charts with flagged concerns need same-day or next-day attention rather than a weekly or monthly batch review. Routine charts can follow a regular cadence, but the review process should be documented either way.
Does chart review cover controlled substance logging?
A proper chart review process for ketamine clinics should confirm controlled substance administration is logged correctly, since Schedule III drugs carry documentation requirements beyond a standard treatment note.
Is software enough for ketamine chart review compliance?
No. Software can flag missing fields or inconsistencies, but it can’t exercise clinical judgment or satisfy the physician-review requirement most states expect. Pair it with a physician-based review model.
What happens if my ketamine clinic doesn’t have chart review?
Missing or inconsistent chart review is one of the first things a state board checks after a complaint or inspection. Clinics without a documented review process risk citations, and in some states, loss of the ability to operate the program.
One last thing
The clinics that get flagged in 2026 usually aren't the ones with bad physicians — they're the ones where chart review exists on paper but nobody can produce a documented history of it when a board asks. Whatever model you pick, make sure the review trail is written down, dated, and easy to pull on demand.
Related guides
